Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
JAPAN / Science & Health
Feb 21, 2021
Fujifilm to restart trial of Avigan to treat COVID-19, report says
Domestic approval of the drug was delayed after a health ministry panel said in December that trial data was inconclusive.
Japan Times
WORLD / Science & Health
Feb 20, 2021
Pfizer’s vaccine works well after one dose and doesn’t always need ultracold storage
A study in Israel showed that the vaccine is robustly effective after the first shot, raising the possibility that regulators in some countries could authorize delaying a second dose.
Japan Times
WORLD
Feb 18, 2021
Pfizer says South African variant could significantly reduce vaccine protection
A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc.-BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday.
Japan Times
JAPAN / Explainer
Feb 17, 2021
This is what you need to know to get a coronavirus vaccine in Japan
More than two months after the U.K. and the U.S., Japan finally embarked on an unprecedented coronavirus vaccination blitz Wednesday.
Japan Times
ASIA PACIFIC
Feb 16, 2021
South Korea reaches deals to buy more COVID-19 vaccines for 23 million people
South Korea has arranged to buy coronavirus vaccines for 23 million more people, its prime minister said on Tuesday, a day after authorities decided to scale back initial vaccination plans, citing delays and efficacy concerns.
Japan Times
WORLD
Feb 16, 2021
WHO approval of AstraZeneca-Oxford vaccine widens access in developing world
The WHO's review found that the vaccine met the 'must-have' criteria for safety and that its efficacy benefits outweighed its risks.
Japan Times
JAPAN / Science & Health
Feb 15, 2021
Japan prepares to dispense Pfizer vaccine from Wednesday after formal approval
Up to 20,000 front-line medical staffers at state-run hospitals are set to be the first to receive the vaccines, followed by 3.7 million other health care workers.
Japan Times
WORLD / Science & Health
Feb 14, 2021
Spread of variants sparks push for all-in-one COVID-19 vaccines
Dangerous coronavirus variants are carpeting the globe, pushing scientists in the U.K. and elsewhere to target multiple versions of the pathogen in a single shot.
Japan Times
ASIA PACIFIC / Science & Health / FOCUS
Feb 8, 2021
China’s COVID-19 vaccine drive is falling behind the U.S. and Europe
The slowness appears to be due to widespread hesitation in the country, including lingering safety concerns, doubts about the level of protection promised and a general lack of urgency.
Japan Times
WORLD
Feb 7, 2021
Putin’s once-scorned vaccine now favorite in pandemic fight
The Russian president may reap diplomatic dividends as the nation basks in arguably its biggest scientific breakthrough since the Soviet era.
Japan Times
WORLD / Science & Health
Feb 7, 2021
Oxford-AstraZeneca COVID-19 shot less effective against South African variant, study says
British drugmaker AstraZeneca said on Saturday its vaccine developed with Oxford University appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19, based on early data from a trial.
Japan Times
JAPAN / Media / MEDIA MIX
Feb 6, 2021
Marijuana law reform in Japan contingent on the message
Japanese authorities have demonstrated a strong resistance to trends in other countries to decriminalize and even commercialize the drug's medicinal and recreational consumption.
Japan Times
JAPAN / Explainer
Feb 5, 2021
Japan is moving closer to vaccinations: Here's how the rollout will work
The government has begun to set out its inoculation schedule, but there are concerns over delivery hiccups.
Japan Times
ASIA PACIFIC
Feb 5, 2021
Macron calls on China to be more transparent on COVID-19 shots
'It seems that we can have more information about the Russian vaccines,” he said, citing a recent study and Russia's initiatives to register its Sputnik V shot with EU authorities.
Japan Times
WORLD / Science & Health
Feb 4, 2021
AstraZeneca and Pfizer vaccines to be combined in Oxford trial
The trial will allow researchers to see whether two shots of different vaccines produce better or worse results than two doses of the same product.
Japan Times
JAPAN
Feb 3, 2021
BioNTech 'confident' it will meet Japan's COVID-19 vaccine demand
Pfizer and BioNTech have increased manufacturing capacity to more than 2 billion doses a year from 1.3 billion to meet demand.
Japan Times
WORLD
Feb 1, 2021
AstraZeneca boosts COVID-19 vaccine deliveries to EU amid chaotic rollout
AstraZeneca PLC will deliver 9 million additional vaccine doses to the European Union in the first quarter of this year as the bloc tries to get its chaotic inoculation drive on track.
Japan Times
WORLD
Jan 31, 2021
COVID-19 mutations undercut optimism even as more vaccines near
Mutations that likely confer partial resistance to vaccines and antibody treatments are now prevalent in both South Africa and Brazil, and they are threatening to spread worldwide.
Japan Times
WORLD
Jan 31, 2021
Faced with a vaccine emergency, the EU made an enemy of everyone
What began as a bid to bring transparency has spiraled into chaotic mud-slinging that some fear could spur a trade row amid the pandemic.
Japan Times
WORLD
Jan 29, 2021
COVID-19 vaccine 89.3% effective in U.K. trial but less so in South Africa, Novavax says
The U.S. company believes the vaccine was 85.6% effective against the highly transmissible U.K. variant, which was also circulating during the study.

Longform

Tetsuzo Shiraishi, speaking at The Center of the Tokyo Raids and War Damage, uses a thermos to explain how he experienced the U.S. firebombing of March 1945, when he was just 7 years old.
From ashes to high-rises: A survivor’s account of Tokyo’s postwar past